Systematically Initiating Insulin

Abstract

Get full access to this article

View all access options for this article.

References

Wright A

Burden AC

Paisey RB

et al.

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care. 2002;25:330-336.

Jain R

Allen E

Wahl T

et al.

Efficacy of biphasic insulin aspart 70/30 in patients with T2DM not achieving glycemic targets on OADs with/without basal insulin therapy. Diabetes. 2005;54:A69.

Riddle MC

Rosenstock J

Gerich JE

et al.

The treat-to-target trial randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003;26:3080-3086.

Raskin P

Allen E

Hollander P

et al.

Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care. 2005;28:260-265.

Mazze RS

Strock E

Simonson GD

et al.

Staged Diabetes Management: Prevention, Detection and Treatment of Diabetes in Adults Quick Guide. 4th ed. Minneapolis, Minnesota: Matrex; 2005.

Grant RW

Buse JB

Meigs, JB

et al.

Quality of care in U.S. academic medical centers. Diabetes Care. 2005;28:337-442.

Garg SK

Gottleib PA

Hisatomi ME

et al.

Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine. Diabetes Res Clin Pract. 2004;66:49-56.

Hamann A

Matthei S

Rosak C

et al.

A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes. Diabetes Care. 2003;26:1738-1744.

Malone JK

Kerr LF

Campaigne BN

et al.

Combined therapy with insulin lispro mix 75/25 plus metformin or insulin glargine plus metformin: a 16 week, randomized, open label, cross-over study in patients with type 2 diabetes beginning insulin therapy. Clin Ther. 2004;26:2034-2044.

10.

Malone JK

Bai S

Campaigne BN

et al.

Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with type 2 diabetes. Diabet Med. 2005;22:374-381.